Literature DB >> 3003619

Brain necrosis after radiotherapy for primary intracerebral tumor.

M L Hohwieler, T C Lo, M L Silverman, S R Freidberg.   

Abstract

Radiotherapy is a standard postoperative treatment for cerebral glioma. We have observed the onset of symptoms related to brain necrosis, as opposed to recurrent tumor, in surviving patients. This has been manifest as dementia with a computed tomographic pattern of low density in the frontal lobe uninvolved with tumor, but within the field of radiotherapy. Two patients presented with mass lesions also unrelated to recurrent tumor. We question the necessity of full brain irradiation and suggest that radiotherapy techniques be altered to target the tumor and not encompass the entire brain.

Entities:  

Mesh:

Year:  1986        PMID: 3003619     DOI: 10.1227/00006123-198601000-00011

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Ramon F Barajas; Jamie S Chang; Mark R Segal; Andrew T Parsa; Michael W McDermott; Mitchel S Berger; Soonmee Cha
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

Review 2.  External beam radiotherapy: hard facts and painful realities.

Authors:  N A Vick; N A Paleologos
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Incidence of late radiation necrosis with transient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas.

Authors:  B Wowra; H P Schmitt; V Sturm
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Early and late stage positron emission tomography (PET) studies on the haemocirculation and metabolism of seemingly normal brain tissue in patients with gliomas following radiochemotherapy.

Authors:  K Mineura; Y Suda; T Yasuda; M Kowada; T Ogawa; F Shishido; K Uemura
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.